Oxford, United Kingdom

Peter Charles Harris

This inventor holds 5 USPTO granted patents. Top assignees: Medical Research Council, Other. Active years: 2001-2003.


% Patents Active = 100.0

Average Co-Inventor Count = 12.0

ph-index = 3

Forward Citations = 34(Granted Patents)


Location History:

  • Oxforrd OX4 4BS, GB (2001)
  • Oxford, GB (2001 - 2003)

Company Filing History:


Years Active: 2001-2003

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Peter Charles Harris

Introduction

Peter Charles Harris is a notable inventor based in Oxford, GB. He has made significant contributions to the field of genetics, particularly in relation to polycystic kidney disease. With a total of 5 patents to his name, Harris has established himself as a key figure in medical research.

Latest Patents

Harris's latest patents include groundbreaking work on the polycystic kidney disease 1 (PKD1) gene. His inventions focus on the nucleic acid sequence of the PKD1 gene, its mutations in patients with PKD1-associated disorders, and the protein encoded by this gene. These patents emphasize the potential uses of the PKD1 gene and its mutants in disease diagnosis and therapy.

Career Highlights

Throughout his career, Harris has been associated with the Medical Research Council, where he has contributed to various research initiatives. His work has been instrumental in advancing our understanding of genetic disorders and their implications for patient care.

Collaborations

Harris has collaborated with esteemed colleagues such as Martin Hendrik Breuning and Jeroen Hendrik Roelfsema. These partnerships have further enriched his research and innovation efforts.

Conclusion

Peter Charles Harris's contributions to the field of genetics, particularly in relation to polycystic kidney disease, highlight his role as an influential inventor. His patents and collaborations continue to pave the way for advancements in medical research and therapy.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…